Daniel Estay

Daniel Estay is a seasoned executive in the medical technology field, currently serving as the Founder and CEO of SonoVascular, Inc., where a multi-mechanism SonoThrombectomy™️ system is being developed for endovascular treatment of venous and arterial diseases. As a Mentor-in-Residence for Duke's Office for Translation & Commercialization, Daniel Estay provides strategic insights for medical device start-ups. Previous roles include Partner at OneMedTech Advisors, President at Verathon, and various leadership positions at Abbott, The Getz Group, Andrx Corporation, Johnson & Johnson, and LeMare Medical, Inc. Daniel Estay holds an MBA in International Business from the University of Miami and a Bachelor of Science in Business Administration from Syracuse University.